M&T Bank Corp decreased its position in shares of Scholar Rock Holding Co. (NASDAQ:SRRK – Free Report) by 30.3% during the ...

Bank of New York Mellon Corp increased its holdings in Scholar Rock Holding Co. (NASDAQ:SRRK – Free Report) by 15.6% during ...

Shares in Scholar Rock have gone into overdrive after the biotech reported positive phase 3 results with apitegromab in patients with spinal muscular atrophy (SMA), setting up regulatory filings ...

CAMBRIDGE, Mass., February 27, 2025--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), ...

The first new album in five years from Car Seat Headrest has been previewed with 11-minute single "Gethsemane." ...

Good morning and welcome to Scholar Rock's Fourth Quarter Financial Results and Business Update Call. All participants will be in listen-only mode. After the company’s prepared remarks all ...

CAMBRIDGE, Mass., February 25, 2025--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy ...

Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders ...

In a regulatory filing, Scholar Rock (SRRK) CEO Jay Backstrom disclosed the sale of 18,372 common shares of the company on February 18 at a price of $36.829 per share. See what stocks are ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic ...

Car Seat Headrest have returned with news of 'The Scholars', their first album in five years, and have debuted their new ...